UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Hydration effect on solid DNA-didecyldimethylammonium chloride complexes measured using 1H-nuclear magnetic resonance spectroscopy

Journal of applied physics, 2013-10, Vol.114 (14)

2013

Volltextzugriff (PDF)

Mild hydration of didecyldimethylammonium chloride modified DNA by 1H-nuclear magnetic resonance and by sorption isotherm

Journal of applied physics, 2013-01, Vol.113 (4)

2013

Volltextzugriff (PDF)

Analysis of the results and long-term follow-up of second-look laparotomy in advanced ovarian cancer

European journal of gynaecological oncology, 2009, Vol.30 (4), p.422-425

2009

Volltextzugriff (PDF)

EP463 Endometrial cancer recurrence in low risk patients - analysis of potential adverse risk factors in the experience of a single center

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A295-A295

2019

Volltextzugriff (PDF)

TREATMENT OF PATIENTS WITH BORDERLINE OVARIAN TUMORS

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.207-207

2004

Volltextzugriff (PDF)

CLINICAL IMPLICATIONS OF RARE HISTOLOGIC TYPES OF ENDOMETRIAL CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.139-139

2004

Volltextzugriff (PDF)

HOW THE DEPTH OF MARKER ADMINISTRATION INFLUENCES THE DETECTION OF SENTINEL NODES IN VULVAR CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.65-65

2004

Volltextzugriff (PDF)

Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for Stage IB2-IIB cervical cancer: EORTC55994

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A12-A12

2019

Volltextzugriff (PDF)

A RETROSPECTIVE STUDY OF 129 OVARIAN EPITHELIAL TUMORS OF BORDERLINE MALIGNANCY

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.41-42

2003

Volltextzugriff (PDF)

QUALITY OF LIVE IN OVARIAN CANCER PATIENTS TREATED FOR RECURRENCES

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.193-194

2004

Volltextzugriff (PDF)

RESPONSE RATE EVALUATION AFTER CHEMOTHERAPY IN PATIENTS WITH STAGE IIIC OVARIAN CARCINOMA

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.223-223

2004

Volltextzugriff (PDF)

COMPARISON OF TOLERANCE OF THERAPY WITH CISPLATIN-CYCLOPHOSPHAMIDE AND PLATINUM- PACLITAXEL AS FIRST LINE CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER STAGE IIIC

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.241-241

2004

Volltextzugriff (PDF)

LONG-TERM SURVIVAL AFTER PRIMARY SURGERY FOLLOWED BY CHEMOTHERAPY FOR STAGE IIIC OVARIAN CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.197-197

2004

Volltextzugriff (PDF)

BIOPSY CORRELATES OF ABNORMAL COLPOSCOPY FINDINGS FOR WOMEN WITH PAPA III SMEAR

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.101-101

2003

Volltextzugriff (PDF)

THE EVALUATION OF COLPOSCOPY EXAMINATION TO VERIFICATION OF PAP III SMEAR IN NORTH REGION OF POLAND IN 2000–2001 YEARS

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.100-101

2003

Volltextzugriff (PDF)

PACLITAXEL HYPERSENSITIVITY REACTIONS IN PATIENTS WITH ADVANCED OVARIAN CARCINOMA

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.52-52

2003

Volltextzugriff (PDF)

COLPOSCOPIC VERIFICATION OF ABNORMAL PAP III SMEAR IN PREVENTION OF CERVICAL CANCER

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.103-103

2003

Volltextzugriff (PDF)

COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.169-170

2004

Volltextzugriff (PDF)

QUALITY OF LIFE IN PATIENTS WITH ADVANCED OVARIAN CANCER TREATED WITH FIRST OR SECOND LINE OF PLATINUM BASED INTRAVENOUS CHEMOTHERAPY

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.52-52

2003

Volltextzugriff (PDF)

INTRAPERITONEAL HYPERTHERMIC PERFUSION CHEMOTHERAPY FOLLOWED BY INTRAPERITONEAL CHEMOTHERAPY IN RECCURENT OVARIAN CANCER

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.46-46

2003

Volltextzugriff (PDF)

Rehydration of CTMA Modified DNA Powders Observed by NMR

Acta physica Polonica, A, 2012-02, Vol.121 (2), p.485-490

2012

Volltextzugriff (PDF)

000411 FACTORS AFFECTING QUALITY OF LIFE IN PATIENTS TREATED FOR PRIMARY DIAGNOSED ADVANCED OVARIAN CANCER AND ITS RECURRENCES

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.165-165

2005

Volltextzugriff (PDF)

ENDOMETRIAL CANCER RECURRENCE IN LOW RISK PATIENTS - ANALYSIS OF POTENTIAL ADVERSE RISK FACTORS IN THE EXPERIENCE OF A SINGLE CENTER: EP463

International journal of gynecological cancer, 2019-11, Vol.29 ESGO Annual Meeting Abstracts, p.A295-A295

2019

Volltextzugriff (PDF)

000411 FACTORS AFFECTING QUALITY OF LIFE IN PATIENTS TREATED FOR PRIMARY DIAGNOSED ADVANCED OVARIAN CANCER AND ITS RECURRENCES

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.165-165

2005

Volltextzugriff (PDF)

Nineteen year old patient with serous ovarian tumors of low malignant potential with non-invasive peritoneal implants: a case report

Ginekologia polska, 2001-08, Vol.72 (8), p.663

2001

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(57)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hydration effect on solid DNA-didecyldimethylammonium chloride complexes measured using 1H-nuclear magnetic resonance spectroscopy

Mild hydration of didecyldimethylammonium chloride modified DNA by 1H-nuclear magnetic resonance and by sorption isotherm

Analysis of the results and long-term follow-up of second-look laparotomy in advanced ovarian cancer

EP463 Endometrial cancer recurrence in low risk patients - analysis of potential adverse risk factors in the experience of a single center

TREATMENT OF PATIENTS WITH BORDERLINE OVARIAN TUMORS

CLINICAL IMPLICATIONS OF RARE HISTOLOGIC TYPES OF ENDOMETRIAL CANCER

HOW THE DEPTH OF MARKER ADMINISTRATION INFLUENCES THE DETECTION OF SENTINEL NODES IN VULVAR CANCER

Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for Stage IB2-IIB cervical cancer: EORTC55994

A RETROSPECTIVE STUDY OF 129 OVARIAN EPITHELIAL TUMORS OF BORDERLINE MALIGNANCY

QUALITY OF LIVE IN OVARIAN CANCER PATIENTS TREATED FOR RECURRENCES

RESPONSE RATE EVALUATION AFTER CHEMOTHERAPY IN PATIENTS WITH STAGE IIIC OVARIAN CARCINOMA

COMPARISON OF TOLERANCE OF THERAPY WITH CISPLATIN-CYCLOPHOSPHAMIDE AND PLATINUM- PACLITAXEL AS FIRST LINE CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER STAGE IIIC

LONG-TERM SURVIVAL AFTER PRIMARY SURGERY FOLLOWED BY CHEMOTHERAPY FOR STAGE IIIC OVARIAN CANCER

BIOPSY CORRELATES OF ABNORMAL COLPOSCOPY FINDINGS FOR WOMEN WITH PAPA III SMEAR

THE EVALUATION OF COLPOSCOPY EXAMINATION TO VERIFICATION OF PAP III SMEAR IN NORTH REGION OF POLAND IN 2000–2001 YEARS

PACLITAXEL HYPERSENSITIVITY REACTIONS IN PATIENTS WITH ADVANCED OVARIAN CARCINOMA

COLPOSCOPIC VERIFICATION OF ABNORMAL PAP III SMEAR IN PREVENTION OF CERVICAL CANCER

COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY

QUALITY OF LIFE IN PATIENTS WITH ADVANCED OVARIAN CANCER TREATED WITH FIRST OR SECOND LINE OF PLATINUM BASED INTRAVENOUS CHEMOTHERAPY

INTRAPERITONEAL HYPERTHERMIC PERFUSION CHEMOTHERAPY FOLLOWED BY INTRAPERITONEAL CHEMOTHERAPY IN RECCURENT OVARIAN CANCER

Rehydration of CTMA Modified DNA Powders Observed by NMR

000411 FACTORS AFFECTING QUALITY OF LIFE IN PATIENTS TREATED FOR PRIMARY DIAGNOSED ADVANCED OVARIAN CANCER AND ITS RECURRENCES

ENDOMETRIAL CANCER RECURRENCE IN LOW RISK PATIENTS - ANALYSIS OF POTENTIAL ADVERSE RISK FACTORS IN THE EXPERIENCE OF A SINGLE CENTER: EP463

000411 FACTORS AFFECTING QUALITY OF LIFE IN PATIENTS TREATED FOR PRIMARY DIAGNOSED ADVANCED OVARIAN CANCER AND ITS RECURRENCES

Nineteen year old patient with serous ovarian tumors of low malignant potential with non-invasive peritoneal implants: a case report

Suchergebnisse filtern